Jenburkt Pharmaceuticals Quarterly Results for Trading Insights

JENBURPH • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹32 Cr
QMarch 2025
Quarterly Results

Jenburkt Pharmaceuticals Quarterly Results Key Highlights

  • Revenue of ₹158 Cr in March 2025 (+0.0% vs March 2025, +7.5% vs March 2024)
  • Net Profit of ₹32 Cr in March 2025 (+0.0% vs March 2025, +23.1% vs March 2024)
  • EBITDA of ₹47 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 27.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹72.65 in March 2025 (+0.0% vs March 2025)

Jenburkt Pharmaceuticals Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 167 158 147 142 129 5.7% -
Net Profit (₹ Cr) 33 32 26 25 22 - -
EBITDA (₹ Cr) 49 47 38 36 32 - -
EPS (₹) 74.80 72.65 58.86 53.90 48.58 - -
Operating Margin (%) 26.0% 27.0% 23.0% 22.0% 22.0% - -

Jenburkt Pharmaceuticals Share Price Trend Around Quarterly Results

Visualize Jenburkt Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Jenburkt Pharmaceuticals share price chart using Tickjournal. All values in ₹.

Related Pages for Jenburkt Pharmaceuticals

Additional stock information and data for JENBURPH

Jenburkt Pharmaceuticals dividend payments
JENBURPH quarterly financials
JENBURPH P/B ratio history
JENBURPH DCF
JENBURPH enterprise value
JENBURPH price trends
Jenburkt Pharmaceuticals P/E valuation

Profitability Ratios

Profit Margin 20.3%
EBITDA Margin 29.7%
Operating Margin 27.0%
ROE (Annual) 18.6%

Balance Sheet Highlights

Total Assets ₹196 Cr
Total Equity ₹172 Cr
Current Assets ₹57 Cr
Current Liabilities ₹6 Cr

Cash Flow Analysis

Operating Cash Flow ₹28 Cr
Investing Cash Flow ₹-17 Cr
Financing Cash Flow ₹-8 Cr
Net Cash Flow ₹3 Cr

Current Market Data

Current Price ₹1148.45
Exchange BSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

March 2023 142
March 2024 147
March 2025 158
2026 167

Net Profit Trend (₹ Cr)

March 2023 25
March 2024 26
March 2025 32
2026 33

Operating Margin Trend (%)

March 2023 22.0%
March 2024 23.0%
March 2025 27.0%
2026 26.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Jenburkt Pharmaceuticals quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores